FibroBiologics Ownership | Who Owns FibroBiologics?
FibroBiologics Ownership Summary
FibroBiologics is owned by 5.17% institutional investors, 17.85% insiders, and 76.98% retail investors. Vanguard group is the largest institutional shareholder, holding 2.82% of FBLG shares.
FBLG Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | FibroBiologics | 5.17% | 17.85% | 76.98% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 1.22M | 2.82% | $273.68K |
| Blackrock funding, inc. /de | 482.40K | 1.12% | $108.49K |
| Geode capital management | 348.76K | 0.81% | $78.47K |
| Cascade financial partners | 314.58K | 0.73% | $70.75K |
| Renaissance | 231.60K | 0.54% | $52.09K |
| Jane street group | 149.76K | 0.35% | $33.68K |
| Amg national trust bank | 138.96K | 0.32% | $31.27K |
| State street | 111.30K | 0.29% | $60.79K |
| Ubs group | 120.77K | 0.28% | $27.17K |
| Wiley bros.-aintree capital | 100.00K | 0.26% | $54.62K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Luminus management | 26.63K | 0.31% | $345.77K |
| Optivise advisory services | 110.10K | 0.01% | $24.76K |
| American institute for advanced investment management, llp | 88.21K | 0.01% | $19.84K |
| Saxon interests | 21.21K | 0.01% | $19.09K |
| Cascade financial partners | 314.58K | 0.01% | $70.75K |
| Requisite capital management | 109.71K | 0.00% | $24.67K |
| Islay capital management | 3.39K | 0.00% | $1.85K |
| Amg national trust bank | 138.96K | 0.00% | $31.27K |
| Global assets advisory | 10.45K | 0.00% | $2.35K |
| Rmr wealth builders | 38.36K | 0.00% | $8.63K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Renaissance | 231.60K | 0.00% | 171.80K |
| Jane street group | 149.76K | - | 149.76K |
| Amg national trust bank | 138.96K | 0.00% | 138.96K |
| Geode capital management | 348.76K | - | 59.81K |
| Ubs group | 120.77K | - | 43.34K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Yorkville advisors global, lp | - | - | -509.79K |
| Landscape capital management | - | - | -350.00K |
| Gts securities | - | - | -308.66K |
| Marshall wace, llp | - | - | -78.62K |
| Charles schwab investment management | - | - | -69.81K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Amg national trust bank | 138.96K | 0.00% | 138.96K | $31.27K |
| Drw securities | 33.35K | 0.00% | 33.35K | $7.50K |
| Luminus management | 26.63K | 0.31% | 26.63K | $345.77K |
| Disciplined equity management | 1.00K | 0.00% | 1.00K | $418.00 |
| Optiver b.v. | 26.00 | - | 26.00 | $14.00 |
Sold Out
| Holder | Change |
|---|---|
| Barclays | -1.00 |
| Ifp advisors | -2.00 |
| Srs capital advisors | -2.00 |
| True wealth design | -10.00 |
| Morgan stanley | -13.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | -69.81% | 2,224,719 | -58.43% | 5 | 2.69% | 4 | -80.95% | 1 | -93.75% |
| Sep 30, 2025 | 18 | -66.04% | 2,042,975 | -56.57% | 5 | 3.57% | 6 | -76.00% | 4 | -71.43% |
| Jun 30, 2025 | 56 | -13.85% | 5,105,357 | -20.53% | 13 | 4.31% | 27 | -18.18% | 16 | 33.33% |
| Mar 31, 2025 | 64 | 4.92% | 6,419,503 | 19.66% | 17 | 6.83% | 32 | 6.67% | 12 | 20.00% |
| Dec 31, 2024 | 62 | 5.08% | 5,939,365 | 8.81% | 17 | 6.68% | 31 | -11.43% | 10 | 66.67% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 04, 2026 | Khoja Hamid | Chief Scientific Officer | Buy | $11.40K |
| Mar 04, 2026 | O'HEERON PETE | CHIEF EXECUTIVE OFFICER | Buy | $6.01K |
| Mar 03, 2026 | O'HEERON PETE | CHIEF EXECUTIVE OFFICER | Buy | $7.37K |
| Mar 02, 2026 | O'HEERON PETE | CHIEF EXECUTIVE OFFICER | Buy | $6.15K |
| Mar 02, 2026 | Davis Jason | Chief Financial Officer | Buy | $28.97K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 6 | - |
| 2025 Q4 | 1 | - |
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
FBLG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools